Wellington Management Group LLP Has $2.87 Million Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Wellington Management Group LLP grew its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 4.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 38,695 shares of the company’s stock after purchasing an additional 1,599 shares during the period. Wellington Management Group LLP’s holdings in Henry Schein were worth $2,873,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Morgan Stanley boosted its position in Henry Schein by 143.4% in the fourth quarter. Morgan Stanley now owns 2,337,890 shares of the company’s stock valued at $186,727,000 after buying an additional 1,377,207 shares in the last quarter. Norges Bank acquired a new stake in shares of Henry Schein during the 4th quarter valued at $109,932,000. Lazard Asset Management LLC boosted its holdings in shares of Henry Schein by 1,303.3% during the 3rd quarter. Lazard Asset Management LLC now owns 1,247,334 shares of the company’s stock valued at $92,614,000 after acquiring an additional 1,158,451 shares in the last quarter. Boston Partners grew its position in Henry Schein by 4,975.9% during the 3rd quarter. Boston Partners now owns 1,080,598 shares of the company’s stock worth $80,229,000 after acquiring an additional 1,059,309 shares during the last quarter. Finally, Point72 Asset Management L.P. acquired a new position in Henry Schein in the 2nd quarter worth about $36,288,000. 96.62% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Piper Sandler boosted their price target on Henry Schein from $78.00 to $86.00 and gave the stock an “overweight” rating in a report on Monday, February 26th. Jefferies Financial Group lifted their target price on shares of Henry Schein from $74.00 to $81.00 and gave the stock a “hold” rating in a research report on Wednesday, March 6th. SVB Leerink initiated coverage on shares of Henry Schein in a research report on Monday, February 26th. They issued a “market perform” rating and a $78.00 price target for the company. StockNews.com cut shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Monday, December 4th. Finally, TheStreet upgraded Henry Schein from a “c+” rating to a “b-” rating in a report on Monday, February 26th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $81.09.

Henry Schein Stock Up 3.1 %

Shares of Henry Schein stock opened at $75.15 on Thursday. The stock’s 50-day moving average is $75.17 and its 200 day moving average is $72.64. Henry Schein, Inc. has a one year low of $60.01 and a one year high of $85.75. The firm has a market cap of $9.66 billion, a price-to-earnings ratio of 23.86, a PEG ratio of 1.81 and a beta of 0.87. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.67 and a quick ratio of 1.00.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, February 27th. The company reported $0.66 EPS for the quarter, missing the consensus estimate of $0.70 by ($0.04). Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. The company had revenue of $3.02 billion for the quarter, compared to analyst estimates of $3 billion. During the same period last year, the business earned $1.21 EPS. The business’s quarterly revenue was down 10.5% compared to the same quarter last year. Equities research analysts anticipate that Henry Schein, Inc. will post 5.07 EPS for the current year.

Insider Buying and Selling at Henry Schein

In other news, Vice Chairman James P. Breslawski sold 2,907 shares of the firm’s stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the sale, the insider now directly owns 209,562 shares in the company, valued at approximately $15,585,125.94. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the transaction, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the transaction, the insider now owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.